Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

High-throughput structure-based pharmacophore modelling as a basis for successful parallel virtual screening.

Theodora M Steindl1, Daniela Schuster, Gerhard Wolber

  • 1Inte:Ligand GmbH, Clemens Maria Hofbauer-Gasse 6, 2344 Maria Enzersdorf, Austria.

Journal of Computer-Aided Molecular Design
|September 30, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Probing 3-Amino-2H-Azaindazoles as Allosteric Inhibitors of the Protein Tyrosine Phosphatase SHP2.

ChemMedChem·2026
Same author

Synthesis and characterization of L-3-(pentafluorophosphato-difluoromethyl)-alanine, a structural and functional mimetic of phosphoserine.

Chemical communications (Cambridge, England)·2026
Same author

Design, synthesis and biological evaluation of novel pyrimidine and quinazoline-based small-molecule Toll-like receptor 8 antagonists.

European journal of medicinal chemistry·2026
Same author

The Kifc3 Motor Protein Controls Centrosomal Factor Cep192 in Ontogenic Coordination of Megakaryocyte Development.

bioRxiv : the preprint server for biology·2026
Same author

Dynamic Pharmacophores Unveil Binding Mode Ensembles for Classical Partial Agonists at the M2 Receptor.

Journal of chemical information and modeling·2026
Same author

Hexahydroquinoline Featuring Amide Functionality: A Promising Scaffold With Calcium Channel Blocking Activity.

Drug development research·2026

Parallel pharmacophore-based virtual screening offers a fast and reliable method for predicting small molecule bioactivity. This in silico approach successfully identified known biological targets for approximately 90% of tested antiviral compounds.

Area of Science:

  • Computational Chemistry
  • Drug Discovery
  • Bioinformatics

Background:

  • Assessing bioactivity profiles of small organic molecules is crucial for drug discovery.
  • Existing methods can be time-consuming and lack scalability for large compound libraries.

Purpose of the Study:

  • To develop and validate a fast, reliable, and scalable system for in silico prediction of small molecule bioactivity profiles.
  • To demonstrate the utility of parallel pharmacophore-based virtual screening for activity profiling.

Main Methods:

  • Utilized LigandScout for structure-based pharmacophore modeling and Catalyst for high-performance database mining.
  • Performed parallel virtual screening of 100 antiviral compounds against 50 pharmacophore models targeting viral proteins.
  • Assessed prediction accuracy by checking for enrichment of pharmacophores matching known ligand targets.

Related Experiment Videos

Main Results:

  • Achieved successful activity profiling for approximately 90% of the screened molecules.
  • Demonstrated that known biological targets could be accurately predicted through pharmacophore matching.
  • Analyzed factors influencing screening results, including search modes and output validation descriptors.

Conclusions:

  • Parallel pharmacophore-based virtual screening is a reliable in silico method for predicting potential biological activities of compounds.
  • This approach enables rapid activity profile prediction for virtual libraries.
  • The study serves as a proof of principle for applying this screening strategy in drug discovery.